158 related articles for article (PubMed ID: 38048862)
1. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
2. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia's biological functions: a focus on the potential role of LncRNAs.
Jalilivand S; Izadirad M; Vazifeh Shiran N; Gharehbaghian A; Naserian S
Clin Exp Med; 2024 May; 24(1):108. PubMed ID: 38777995
[TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
[TBL] [Abstract][Full Text] [Related]
4. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review].
Fang ZH; Zheng SY; Feng WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
[TBL] [Abstract][Full Text] [Related]
5. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
7. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
9. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
[TBL] [Abstract][Full Text] [Related]
10. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB
Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.
Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L
Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
Huang P; Wang L; Li Q; Tian X; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Cheng K; Qian L; Yang Y
Cardiovasc Res; 2020 Feb; 116(2):353-367. PubMed ID: 31119268
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
17. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
18. FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.
Liu N; Liu C; Wang Z; Wang L; Wang J; Kong J
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):307-315. PubMed ID: 36628934
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts.
Yang Y; Li J; Geng Y
J Biochem; 2020 Nov; 168(5):491-498. PubMed ID: 32770182
[TBL] [Abstract][Full Text] [Related]
20. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
